Use of sodium–glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020

Matthew J.L. Hare; Winnie Chen; Thomas Berhane; Sumaria M. Corpus; Louise J. Maple-Brown

doi:10.1111/imj.16653

Use of sodium–glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020

Matthew J.L. Hare, Winnie Chen, Thomas Berhane, Sumaria M. Corpus, Louise J. Maple-Brown

Research output: Contribution to journal › Article › peer-review

1 Downloads (Pure)

Abstract

Aboriginal people in remote Northern Territory communities experience the highest burden of type 2 diabetes (T2D) globally. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) improve cardiac and renal outcomes in selected populations. However, safety in this context is unknown. We investigated SGLT2i use and outcomes in remote Aboriginal people with T2D between 2012 and 2020.

Original language	English
Pages (from-to)	518-522
Number of pages	5
Journal	Internal Medicine Journal
Volume	55
Issue number	3
Early online date	24 Feb 2025
DOIs	https://doi.org/10.1111/imj.16653
Publication status	Published - Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/imj.16653

125278537-oaFinal published version, 648 KBLicence: CC BY

Cite this

@article{d7750982c2804503bbf3e3cfce7d8eaa,

title = "Use of sodium–glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020",

abstract = "Aboriginal people in remote Northern Territory communities experience the highest burden of type 2 diabetes (T2D) globally. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) improve cardiac and renal outcomes in selected populations. However, safety in this context is unknown. We investigated SGLT2i use and outcomes in remote Aboriginal people with T2D between 2012 and 2020.",

keywords = "general practice, indigenous health, pharmacoepidemiology, primary care, rural health service, type 2 diabetes",

author = "Hare, {Matthew J.L.} and Winnie Chen and Thomas Berhane and Corpus, {Sumaria M.} and Maple-Brown, {Louise J.}",

year = "2025",

month = mar,

doi = "10.1111/imj.16653",

language = "English",

volume = "55",

pages = "518--522",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Use of sodium–glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory

T2 - 2012 to 2020

AU - Hare, Matthew J.L.

AU - Chen, Winnie

AU - Berhane, Thomas

AU - Corpus, Sumaria M.

AU - Maple-Brown, Louise J.

PY - 2025/3

Y1 - 2025/3

N2 - Aboriginal people in remote Northern Territory communities experience the highest burden of type 2 diabetes (T2D) globally. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) improve cardiac and renal outcomes in selected populations. However, safety in this context is unknown. We investigated SGLT2i use and outcomes in remote Aboriginal people with T2D between 2012 and 2020.

AB - Aboriginal people in remote Northern Territory communities experience the highest burden of type 2 diabetes (T2D) globally. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) improve cardiac and renal outcomes in selected populations. However, safety in this context is unknown. We investigated SGLT2i use and outcomes in remote Aboriginal people with T2D between 2012 and 2020.

KW - general practice

KW - indigenous health

KW - pharmacoepidemiology

KW - primary care

KW - rural health service

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85218682989&partnerID=8YFLogxK

U2 - 10.1111/imj.16653

DO - 10.1111/imj.16653

M3 - Article

AN - SCOPUS:85218682989

SN - 1444-0903

VL - 55

SP - 518

EP - 522

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 3

ER -

Use of sodium–glucose cotransporter-2 inhibitors among Aboriginal people with type 2 diabetes in remote Northern Territory: 2012 to 2020

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this